Form 4: Merit Medical Systems Director Executes Stock Option and Sells Shares

Director F. Ann Millner exercised stock options and sold shares of Merit Medical Systems Inc. on November 15, 2024, under a pre-arranged trading plan.

Summary

• F. Ann Millner, a director at Merit Medical Systems Inc., exercised 12,500 stock options at a price of $50.50 per share on November 15, 2024.
• Simultaneously, Ms. Millner sold 12,500 shares of common stock at a weighted average price of $101.55 per share.
• The sales were executed under a Rule 10b5-1 trading plan adopted on August 7, 2023.
• Following these transactions, Ms. Millner directly owns 32,391 shares of Merit Medical Systems Inc. common stock.
• The stock options were granted at various dates and vest in installments.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a stock transaction by a director. It doesn't indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for all publicly traded companies in the US.
• The use of a 10b5-1 trading plan is a common method for insiders to manage their stock transactions while avoiding accusations of insider trading.
• The vesting schedules of the options are typical for executive compensation packages.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider trading activity.
• The sale of shares by a director could have a minor impact on the stock price, but the pre-arranged nature of the trades mitigates this risk.

Key Dates

Keywords

stock options, insider trading, Form 4, Rule 10b5-1, MMSI, Merit Medical Systems, stock sale, director